PSA Screening Cuts Prostate Cancer Mortality, Review Finds

A new systematic review of six large-scale trials involving nearly 800,000 men in Europe and North America has found that prostate-specific antigen (PSA) blood testing significantly lowers prostate cancer mortality rates. Published this week, the analysis provides moderate certainty of benefits for